Back to News
2019 IQ CPLG and TALG FDA Meeting
![2019 IQ CPLG and TALG FDA Meeting](/images/made/impact_news_800_712_70.png)
October 15, 2019
On 15 October 2019, the IQ Clinical Pharmacology Leadership Group (CPLG) and Translational and ADME Sciences Leadership Group (TALG) was honored to participate in a scientific exchange meeting with the FDA Office of Clinical Pharmacology. IQ presented on, and discussed, cell and gene therapies, and participated in roundtable discussions with FDA on the Model-Informed Drug Development (MIDD) pilot program and Physiologically Based Pharmacokinetic (PBPK) modeling for food effects.